UNITED STATES
                   SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C. 20549

                               FORM 12b-25

NOTIFICATION OF LATE FILING            SEC FILE NUMBER: 000-28827

                                        CUSIP NUMBER: ____________

[ ]Form 10-K [ ]Form 20-F  [ ] Form 11-K  [X] Form 10-Q
[ ]Form N-SAR

For Period Ended: June 30, 2001
                 ----------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[X] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:

     Read Attached Instruction Sheet Before Preparing Form.  Please Print or
Type.  Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.

     If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION
- -------------------------------

     Full Name of Registrant

      PETMED EXPRESS, INC.
- ----------------------------------------------------------------------------
     Former Name if Applicable

      N/A
- ----------------------------------------------------------------------------

Address of Principal Office (Street and Number)

      1441 S.W. 29th Avenue
- ----------------------------------------------------------------------------

City, State and Zip Code

 Pompano Beach, Florida, 33069
- ----------------------------------------------------------------------------


PART II - RULES 12b-25(b) AND (c)
- ---------------------------------

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.  (Check box if appropriate)

[X] (a)   The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expense.


   1


[X] (b)   The subject annual report, semi-annual report, transition report on
          Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will
          be filed on or before the fifteenth calendar day following the
          prescribed due date; or the subject quarterly report or transition
          report on Form 10-Q, or portion thereof will be filed on or before
          the fifth calendar day following the prescribed due date; and
[ ] (c)   The accountant's statement or other exhibit required by Rule
          12b-25(c) has been attached if applicable.


PART III - NARRATIVE
- --------------------

The filing of Form 10-Q could not be filed within the prescribed time
period due to the fact that the Company has recently hired two new
executive officers, a new Chief Executive Officer, Mendo Akdag, and a new
Chief Financial Officer, Bruce S. Rosenbloom.  Also, the Company has
engaged new external auditors, Goldstein, Golub, & Kessler, LLP.  Due to
the fact that all parties mentioned above are new to the Company an
additional 5 days is deemed necessary to ensure the entire Form 10-Q filing
is complete and accurate.


PART IV - OTHER INFORMATION
- ---------------------------

(1)  Name and telephone number of person to contact in regard to this
notification.

     Bruce S. Rosenbloom              954            979 5995
          (Name)                   (Area Code)  (Telephone Number)

(2)  Have all other period reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such short period that the
registrant was required to file such report(s) been filed?  If answer is no,
identify report(s).

                          [X] Yes        [ ] No

(3)  Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected in
the earnings statement to be included in the subject report or portion
thereof?

                          [ ] Yes        [X] No

     If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.


   2


    The Registrant, PETMED EXPRESS, INC., has caused this notification to be
signed on its behalf by the undersigned hereunto duly authorized.




Date: August 13, 2001              BY:_____/s/Bruce S. Rosenbloom___________
                                      Bruce S. Rosenbloom, CFO


    3